J Korean Med Sci.  2020 Jul;35(27):e250. 10.3346/jkms.2020.35.e250.

Social Distancing and Lessons from Sweden's Lenient Strategy against Corona Virus Disease 2019

• Yoo JH

• KMID: 2504266
• DOI: http://doi.org/10.3346/jkms.2020.35.e250

Reference

1. Jang WM, Jang DH, Lee JY. Social distancing and transmission-reducing practices during the 2019 coronavirus disease and 2015 Middle East respiratory syndrome coronavirus outbreaks in Korea. J Korean Med Sci. 2020; 35(23):e220. PMID: 32537955.

2. Feng Z, Glasser JW, Hill AN. On the benefits of flattening the curve: a perspective. Math Biosci. 2020; 326:108389. PMID: 32473161.

3. Ryu S, Ali ST, Cowling BJ, Lau EH. Effects of school holidays on seasonal influenza in South Korea, 2014-2016. J Infect Dis. 2020; jiaa179. PMID: 32277239.

4. Cauchemez S, Ferguson NM, Wachtel C, Tegnell A, Saour G, Duncan B, et al. Closure of schools during an influenza pandemic. Lancet Infect Dis. 2009; 9(8):473–481. PMID: 19628172.

5. Kim S, Kim YJ, Peck KR, Jung E. School opening delay effect on transmission dynamics of coronavirus disease 2019 in Korea: Based on mathematical modeling and simulation study. J Korean Med Sci. 2020; 35(13):e143. PMID: 32242349.

6. Giesecke J. The invisible pandemic. Lancet. 2020; 395(10238):e98. PMID: 32539940.

7. Paterlini M. ‘Closing borders is ridiculous’: the epidemiologist behind Sweden's controversial coronavirus strategy. Nature. 2020; 580(7805):574.

8. COVID-19 Dashboard (South Korea). Updated 2020. Accessed June 30, 2020. https://coronaboard.kr/en/.

9. SVT Datajournalistik. Updated 2020. Accessed June 30, 2020. https://www.svt.se/datajournalistik/the-spread-of-the-coronavirus/.

10. Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. 2020; 382(22):2081–2090. PMID: 32329971.

11. He X, Lau EH, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020; 26(5):672–675. PMID: 32296168.

12. Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. Forthcoming. 2020; DOI:10.1038/s41591-020-0965-6.

13. Channappanavar R, Zhao J, Perlman S. T cell-mediated immune response to respiratory coronaviruses. Immunol Res. 2014; 59(1-3):118–128. PMID: 24845462.

14. Choi JY, Oh JO, Ahn JY, Choi H, Kim JH, Seong H, et al. Absence of neutralizing activity in serum 1 year after successful treatment with antivirals and recovery from MERS in South Korea. Clin Exp Vaccine Res. 2019; 8(1):86–88. PMID: 30775355.

15. Payne DC, Iblan I, Rha B, Alqasrawi S, Haddadin A, Al Nsour M, et al. Persistence of antibodies against Middle East respiratory syndrome coronavirus. Emerg Infect Dis. 2016; 22(10):1824–1826. PMID: 27332149.

16. Wu LP, Wang NC, Chang YH, Tian XY, Na DY, Zhang LY, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007; 13(10):1562–1564. PMID: 18258008.

17. Taiwan Centers for Disease Control. Updated 2020. Accessed June 30, 2020. https://www.cdc.gov.tw/En.

18. Ryu S, Gao H, Wong JY, Shiu EY, Xiao J, Fong MW, et al. Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings-international travel-related measures. Emerg Infect Dis. 2020; 26(5):961–966. PMID: 32027587.

19. Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020; 368(6489):395–400. PMID: 32144116.

20. Wells CR, Sah P, Moghadas SM, Pandey A, Shoukat A, Wang Y, et al. Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak. Proc Natl Acad Sci U S A. 2020; 117(13):7504–7509. PMID: 32170017.

21. Korean Ministry of the Interior and Safety. Updated 2020. Accessed June 30, 2020. https://www.mois.go.kr/eng/a01/engMain.do.